Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Validation of Low Risk Prognostic Scoring System (LR-PSS) in Patients with Lower Risk IPSS-R Myelodysplastic Syndrome. Results from a Single Center

Montserrat Arnan Sangerman, MD PhD, Helena Pomares, MD PhD, Esther Alonso, MD, Mercedes Galiano, Maite Encuentra, Javier Grau, MD PhD, Anna Sureda, MD PhD

Blood (2019) 134 (Supplement_1): 4270.

https://doi.org/10.1182/blood-2019-127901

Published: 2019

Journal Articles

Impact of Red Blood Cell Transfusion Burden Status in Patients with Lower-Risk Myelodysplastic Syndromes

Montserrat Arnan Sangerman, Helena Pomares, MD PhD, Esther Alonso, MD, Javier Grau, MD PhD, Mercedes Galiano, Maite Encuentra, Anna Sureda, MD PhD

Blood (2019) 134 (Supplement_1): 3013.

https://doi.org/10.1182/blood-2019-127486

Published: 2019

Journal Articles

Therapy-Related MDS Can be Separated into Different Risk-Groups According to Tools for Classification and Prognostication of Primary MDS

Andrea Kuendgen, MD, Meritxell Nomdedeu, Heinz Tuechler, Guillermo Garcia-Manero, MD, Rami S. Komrokji, MD, Mikkael A. Sekeres, MD MS, Matteo Giovanni Della Porta, Alan F. List, MD, Mario Cazzola, Amy E. DeZern, MD, Gail J. Roboz, MD, David P. Steensma, MD, Arjan A. Van de Loosdrecht, MD PhD, Hartmut Döhner, MD, Xavier Calvo, MD, Sabine Blum, Arturo Pereira, MD PhD, Peter Valent, Dolors Costa, Aristoteles Giagounidis, Luis Benlloch, Uwe Platzbecker, Carme Pedro, MD, Michael Lübbert, Itziar Oiartzabal, Javier Grau, Maria Díez-Campelo, María Teresa Cedena, Sigrid Machherndl-Spandl, MD, Maria López-Pavía, Claudia D. Baldus, MD, Montserra Martinez-de-Sola, Reinhard Stauder, MD MSc, Brayan Merchan, Christina Ganster, Thomas Schroeder, Barbara Hildebrandt, Jordi Esteve, MD PhD, Benet Nomdedeu, Francesc Cobo, Francesc Sole, PhD, Rainer Haas, MD, Ulrich Germing, MD, Peter L Greenberg, MD, Detlef Haase, MD PhD, Guillermo Sanz

Blood (2018) 132 (Supplement 1): 3103.

https://doi.org/10.1182/blood-2018-99-118215

Published: 2018

Journal Articles

Comparison of Clinical Characteristics and Prognosis of a Series of Patients from the Spanish Registry of MDS Diagnosed with Myelodysplastic/Myeloproliferative Neoplasms According to the 2016 Reviewed Classification of the World Health Organization

Blood (2018) 132 (Supplement 1): 3048.

https://doi.org/10.1182/blood-2018-99-111883

Published: 2018

Journal Articles

An IPSS-R Cutpoint of 3 Stratified Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) Patients (pts) into Two Risk Groups

Julia Montoro, Helena Pomares, Brayan Merchan, Antonieta Molero, Silvia Saumell, Esther Alonso, Mónica Fernández, Laura Gallur, Javier Grau, Olga Salamero, Adoración Blanco, Anna Varela, Elisa Roldán, Anna Sureda, Francesc Bosch, Montserrat Arnan Sangerman, David Valcarcel

Blood (2017) 130 (Supplement 1): 5306.

https://doi.org/10.1182/blood.V130.Suppl_1.5306.5306

Published: 2017

Journal Articles

Prognostic VALUE of EARLY Drop in the Platelet Counts in Patients with VERY Low, Low and Intermediate Risk IPSS-R Myelodysplastic Syndromes. Results from a Single Center Analysis

Helena Pomares, Isabel Sánchez-Ortega, MD PhD, Javier Grau, MD PhD, Esther Alonso, Maite Encuentra, Anna Sureda, Montserrat Arnan Sangerman

Blood (2017) 130 (Supplement 1): 2968.

https://doi.org/10.1182/blood.V130.Suppl_1.2968.2968

Published: 2017

Journal Articles

Frequency and Prognostic Significance of the Presence of Additional Cytogenetic Abnormalitions (ACA) to the Philadelphia (Ph) Chromosome in Young Adults with ACUTE Lymphoblastic Leukemia (ALL) Treated with the ALL Ph08 Trial from the Pethema Group

Blood (2016) 128 (22): 1602.

https://doi.org/10.1182/blood.V128.22.1602.1602

Published: 2016

Journal Articles

Improving Risk Stratification of Patients with Myelodysplastic Syndromes By the Integration of Red Blood Cell Transfusion Dependency into the Revised International Prognostic Scoring System

Montserrat Arnan, Helena Pomares, Isabel Sánchez-Ortega, MD PhD, Ester Alonso, MD, Maria Condom, Maite Encuentra, Javier Grau, Anna Sureda, MD PhD

Blood (2016) 128 (22): 3178.

https://doi.org/10.1182/blood.V128.22.3178.3178

Published: 2016

Journal Articles

Isolate Loss of Y Chromosome Decreases the Risk of Leukemic Transformation in the Myelodysplastic Syndromes. a Study By the Spanish Group of Myelodysplastic Syndromes

Blood (2016) 128 (22): 4331.

https://doi.org/10.1182/blood.V128.22.4331.4331

Published: 2016

Journal Articles

Validation of the Low Risk Prognostic Scoring System (LR-PSS) in Patients with VERY Low, Low and Intermediate Risk IPSS-R Myelodysplastic Syndrome. Results from a Single Center

Helena Pomares, MD, Isabel Sánchez-Ortega, MD PhD, Esther Alonso, MD, Javier Grau, MD, Rafael F. Duarte, MD PhD, Anna Sureda, MD PhD, Montserrat Arnan, MD PhD

Blood (2015) 126 (23): 2902.

https://doi.org/10.1182/blood.V126.23.2902.2902

Published: 2015

Journal Articles

Molecular Genetic Profiling in Chronic Myelomonocytic Leukemia with Low Risk Cytogenetic Features

Laura Palomo, MSc, Blanca Xicoy, MD PhD, Montse Arnan, MD, Marta Cabezon, Rosa Coll, MD, Vera Ademà, MSc, Francisco Fuster, MSc, Javier Grau, MD, María José Jiménez, Helena Pomares, MD, Sílvia Marcé, PhD, Maria Pilar Armengol, PhD, Mar Mallo, PhD, Fuensanta Millá, MD PhD, Evarist Feliu, MD PhD, Francesc Sole, PhD, Lurdes Zamora, PhD

Blood (2015) 126 (23): 2883.

https://doi.org/10.1182/blood.V126.23.2883.2883

Published: 2015

Journal Articles

Utility of SNP Arrays in Chronic Myelomonocytic Leukemia with Low Risk Cytogenetic Features or No Metaphases

Blood (2014) 124 (21): 4659.

https://doi.org/10.1182/blood.V124.21.4659.4659

Published: 2014

Journal Articles

Prognostic Value of Chromosome 1 Abnormalities in Myelodysplastic Syndrome

Blood (2014) 124 (21): 3240.

https://doi.org/10.1182/blood.V124.21.3240.3240

Published: 2014

Journal Articles

Chromosome 8 Abnormalities (8p Losses and 8q Gains) in Patients with Chronic Lymphocytic Leukemia (CLL) and Del(17p)

Blood (2014) 124 (21): 5638.

https://doi.org/10.1182/blood.V124.21.5638.5638

Published: 2014

Journal Articles

Characterization of Cytogenetic Abnormalities and Mutations in ASXL1, SRSF2, CBL and JAK2 Genes in Chronic Myelomonocytic Leukemia

Laura Palomo, Blanca Xicoy, MD, PhD, Silvia Marce, PhD, Olga Garcia, Marta Cabezon, María José Jiménez, Isabel Granada, Javier Grau, MD, Josep-Maria Ribera, MD, PhD, Evarist Feliu, MD, PhD, Fuensanta Millá, MD, PhD, Lurdes Zamora, PhD

Blood (2012) 120 (21): 4809.

https://doi.org/10.1182/blood.V120.21.4809.4809

Published: 2012

Journal Articles

Prognostic Value of Complex Karyotype and Monosomal Karyotype in Patients with Adult Acute Lymphoblastic Leukemia Treated with Risk-Adapted Protocols

Blood (2012) 120 (21): 4785.

https://doi.org/10.1182/blood.V120.21.4785.4785

Published: 2012

Journal Articles

Role of ABL Gene Mutations in Chronic Myeloid Leukemia Patients Resistant to Imatinib and Results of Treatment Shift to Second-Generation Tyrosine Kinase Inhibitors

Blood (2011) 118 (21): 4442.

https://doi.org/10.1182/blood.V118.21.4442.4442

Published: 2011

Journal Articles

Frequency and Prognosis of Clonal Chromosomal Abnormalities Following Stem Cell Transplantation (SCT) in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Blood (2011) 118 (21): 4897.

https://doi.org/10.1182/blood.V118.21.4897.4897

Published: 2011

Journal Articles

hOCT1 Gene Expression Might Predict Molecular Response In Patients with Chronic Myeloid Leukemia

Lurdes Zamora, PhD, Marta Cabezon, Concha Boqué, MD, PhD, Silvia Marce, PhD, Jordi Ribera, Diana Dominguez, Isabel Granada, Javier Grau, Blanca Xicoy, Cristalina Fernandez, Alberto Fernandez de Sevilla, MD, PhD, David Gallardo, MD, PhD, Josep-Maria Ribera, MD, PhD, Fuensanta Millá, MD, PhD, Evarist Feliu, MD, PhD

Blood (2010) 116 (21): 4838.

https://doi.org/10.1182/blood.V116.21.4838.4838

Published: 2010

Journal Articles

Prognostic Impact of Additional Chromosomal Aberrations (ACA) to 5q- in Patients with primary Myelodysplastic Syndrome.

Blood (2008) 112 (11): 1649.

https://doi.org/10.1182/blood.V112.11.1649.1649

Published: 2008

NARROW

Validation of Low Risk Prognostic Scoring System (LR-PSS) in Patients with Lower Risk IPSS-R Myelodysplastic Syndrome. Results from a Single Center

Impact of Red Blood Cell Transfusion Burden Status in Patients with Lower-Risk Myelodysplastic Syndromes

Therapy-Related MDS Can be Separated into Different Risk-Groups According to Tools for Classification and Prognostication of Primary MDS

Comparison of Clinical Characteristics and Prognosis of a Series of Patients from the Spanish Registry of MDS Diagnosed with Myelodysplastic/Myeloproliferative Neoplasms According to the 2016 Reviewed Classification of the World Health Organization

An IPSS-R Cutpoint of 3 Stratified Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) Patients (pts) into Two Risk Groups

Prognostic VALUE of EARLY Drop in the Platelet Counts in Patients with VERY Low, Low and Intermediate Risk IPSS-R Myelodysplastic Syndromes. Results from a Single Center Analysis

Frequency and Prognostic Significance of the Presence of Additional Cytogenetic Abnormalitions (ACA) to the Philadelphia (Ph) Chromosome in Young Adults with ACUTE Lymphoblastic Leukemia (ALL) Treated with the ALL Ph08 Trial from the Pethema Group

Improving Risk Stratification of Patients with Myelodysplastic Syndromes By the Integration of Red Blood Cell Transfusion Dependency into the Revised International Prognostic Scoring System

Isolate Loss of Y Chromosome Decreases the Risk of Leukemic Transformation in the Myelodysplastic Syndromes. a Study By the Spanish Group of Myelodysplastic Syndromes

Validation of the Low Risk Prognostic Scoring System (LR-PSS) in Patients with VERY Low, Low and Intermediate Risk IPSS-R Myelodysplastic Syndrome. Results from a Single Center

Molecular Genetic Profiling in Chronic Myelomonocytic Leukemia with Low Risk Cytogenetic Features

Utility of SNP Arrays in Chronic Myelomonocytic Leukemia with Low Risk Cytogenetic Features or No Metaphases

Prognostic Value of Chromosome 1 Abnormalities in Myelodysplastic Syndrome

Chromosome 8 Abnormalities (8p Losses and 8q Gains) in Patients with Chronic Lymphocytic Leukemia (CLL) and Del(17p)

Characterization of Cytogenetic Abnormalities and Mutations in ASXL1, SRSF2, CBL and JAK2 Genes in Chronic Myelomonocytic Leukemia

Prognostic Value of Complex Karyotype and Monosomal Karyotype in Patients with Adult Acute Lymphoblastic Leukemia Treated with Risk-Adapted Protocols

Role of ABL Gene Mutations in Chronic Myeloid Leukemia Patients Resistant to Imatinib and Results of Treatment Shift to Second-Generation Tyrosine Kinase Inhibitors

Frequency and Prognosis of Clonal Chromosomal Abnormalities Following Stem Cell Transplantation (SCT) in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

hOCT1 Gene Expression Might Predict Molecular Response In Patients with Chronic Myeloid Leukemia

Prognostic Impact of Additional Chromosomal Aberrations (ACA) to 5q- in Patients with primary Myelodysplastic Syndrome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only